InvestorsHub Logo
Followers 44
Posts 1911
Boards Moderated 0
Alias Born 04/09/2016

Re: None

Wednesday, 02/15/2017 8:49:06 AM

Wednesday, February 15, 2017 8:49:06 AM

Post# of 8355
http://pages.stern.nyu.edu/~adamodar/New_Home_Page/datafile/pedata.html


Biotech stocks industry average current P/E ratio is 361.


361*500k revenues = $180,000,000

$180,000,000/4,000,000 (float) = $45.10 per share

$180,000,000/40,000,000 (outstanding shares) = $4.51 per share


No matter how you look at it, we are undervalued. Anything under $4 is a gem.

You guys do realize that every 500k in revenue could DOUBLE the pps and that they just signed a joint venture to invent and develop 2 cannabis drugs for breast cancer and neuropathy and several other nutraceuticals.

Pharmaceutical and Biotech companies raked in BILLIONS last year of producing new drugs.

This company is already a profitable company with 500k in revenues and they are GROWING!!!!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ETST News